Fresenius SE & Co. KGaA

Investor News 2008

23.12.2008	Phase II study shows trifunctional antibody Removab® (catumaxomab) well tolerated in treatment of gastric cancer
	Text as PDF file
22.12.2008	HELIOS awarded two hospital privatization projects in Germany
	Text as PDF file
02.12.2008	Capital Market Day: Fresenius Helios and Fresenius Vamed poised for continued growth
	Text as PDF file
04.11.2008	Q1-3/2008: Continued strong growth − Sales outlook raised
	Text as PDF file
30.09.2008	Syndicated Credit Facilities for APP Pharmaceuticals acquisition financing increased by US$ 500 million due to strong demand
	Text as PDF file
10.09.2008	Fresenius closes APP acquisition
	Text as PDF file
02.09.2008	Fresenius and APP Pharmaceuticals Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
	Text as PDF file
28.08.2008	Moody’s confirms Fresenius SE’s Ba1 rating
	Text as PDF file
12.08.2008	Fresenius SE successfully completes capital increase
	Text as PDF file
11.08.2008	Acquisition of Dabur Pharma successfully closed
	Text as PDF file
11.08.2008	Substantial oversubscription in first phase of syndication of US$ 2,400 million Senior Secured Credit Facilities
	Text as PDF file
11.08.2008	Fresenius resolves on capital increase
	Text as PDF file
30.07.2008	First half 2008: Strong financial results
	Text as PDF file
17.07.2008	Strong financial results in the first half of 2008 (preliminary figures)
	Text as PDF file
17.07.2008	Issuance of mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care AG & Co. KGaA
	Text as PDF file
17.07.2008	Fresenius SE successfully executes offering of € 554 million mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care
	Text as PDF file
07.07.2008	Fresenius Kabi to acquire APP Pharmaceuticals – entry into North American I.V. generics market provides excellent growth opportunities
	Text as PDF file
20.05.2008	Moody's upgrades rating of Fresenius SE to Ba1
	Text as PDF file
30.04.2008	Q1 2008: Successful start into 2008
	Text as PDF file
20.04.2008	Fresenius Kabi strengthens its position in i.v. drugs by acquiring Dabur Pharma, a leading manufacturer of oncology generics
	Text as PDF file
20.02.2008	Fresenius achieves record financial results in 2007 - All financial targets met or exceeded
	Text as PDF file
20.02.2008	Consolidated Statement of Income, Balance Sheet, Cash Flow 2007 - US-GAAP as PDF

Home > Investor Relations > News > Investor News > 2008